Centers of Biomedical Research Excellence: Development Phase (COBRE-D)
National Institutes of Health
Classification and identifiers
- Solicitation number
- PAR-26-027
- Assistance listing (CFDA)
- 93.859
Amount
Amount not published by the funder
Who can apply
Eligibility is restricted to institutions that meet the following criteria:Are located in an IDeA-eligible state, commonwealth, or jurisdiction, which are Alaska, Arkansas, Delaware, Hawaii, Idaho, Kansas, Kentucky, Louisiana, Maine, Mississippi, Montana, Nebraska, Nevada, New Hampshire, New Mexico, North Dakota, Oklahoma, Puerto Rico, Rhode Island, South Carolina, South Dakota, Vermont, West Virginia, and Wyoming; andAward doctoral degrees in the health-related sciences or are independent biomedical research institutes/medical centers with ongoing biomedical research programs funded by the NIH or other federal agencies.
About this opportunity
The NIGMS Institutional Development Awards (IDeA) program supports biomedical research capacity building in states that have historically received low levels of NIH funding. The Centers of Biomedical Research Excellence: Development Phase (COBRE-D) program provides funding to enable institutions in IDeA states to increase their biomedical research capacity in broad scientific areas of strategic importance to them but for which they have limited existing infrastructure or expertise. COBRE-D is intended to support a long-term institutional vision focused on the recruitment and mentoring of early-career investigators by supplementing start-up packages for new hires, the establishment of research facilities, and enhancement of research administration support services. This program serves as an...
Related opportunities
- Limited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) (P30 - Clinical Trial Not Allowed)National Institutes of HealthCloses May 2029
- IDeA Networks of Biomedical Research Excellence (INBRE)National Institutes of Health
- Centers of Excellence in Genomic Science (CEGS)National Institutes of Health
- Centers for Genomics Research Capacity BuildingNational Institutes of Health
- Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2027, 2028, and 2029 (P50 Clinical Trial Required)National Institutes of Health
- National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)National Institutes of Health